These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11268826)

  • 1. Screening and diagnosis of anxiety and mood disorders in substance abuse patients.
    Franken IH; Hendriks VM
    Am J Addict; 2001; 10(1):30-9. PubMed ID: 11268826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCL-90-R as a screening instrument for severe personality disturbance among outpatients with mood and anxiety disorders.
    Starcevic V; Bogojevic G; Marinkovic J
    J Pers Disord; 2000; 14(3):199-207. PubMed ID: 11019744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced abortion and anxiety, mood, and substance abuse disorders: isolating the effects of abortion in the national comorbidity survey.
    Coleman PK; Coyle CT; Shuping M; Rue VM
    J Psychiatr Res; 2009 May; 43(8):770-6. PubMed ID: 19046750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for psychopathology in the clinical practice.
    Eland-Goossensen A; van de Goor I; Garretsen H; Schudel J
    J Subst Abuse Treat; 1997; 14(6):585-91. PubMed ID: 9437632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological associations between gambling behavior, substance use & mood and anxiety disorders.
    el-Guebaly N; Patten SB; Currie S; Williams JV; Beck CA; Maxwell CJ; Wang JL
    J Gambl Stud; 2006; 22(3):275-87. PubMed ID: 17009123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse childhood experiences in relation to mood and anxiety disorders in a population-based sample of active military personnel.
    Sareen J; Henriksen CA; Bolton SL; Afifi TO; Stein MB; Asmundson GJ
    Psychol Med; 2013 Jan; 43(1):73-84. PubMed ID: 22608015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.
    Brown TA; Campbell LA; Lehman CL; Grisham JR; Mancill RB
    J Abnorm Psychol; 2001 Nov; 110(4):585-99. PubMed ID: 11727948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders.
    Kessler RC; Calabrese JR; Farley PA; Gruber MJ; Jewell MA; Katon W; Keck PE; Nierenberg AA; Sampson NA; Shear MK; Shillington AC; Stein MB; Thase ME; Wittchen HU
    Psychol Med; 2013 Aug; 43(8):1625-37. PubMed ID: 23075829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder.
    Grilo CM; White MA; Masheb RM
    Int J Eat Disord; 2009 Apr; 42(3):228-34. PubMed ID: 18951458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidity: prevalence in methadone maintenance treatment.
    Milby JB; Sims MK; Khuder S; Schumacher JE; Huggins N; McLellan AT; Woody G; Haas N
    Am J Drug Alcohol Abuse; 1996 Feb; 22(1):95-107. PubMed ID: 8651147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology.
    Merikangas KR; Mehta RL; Molnar BE; Walters EE; Swendsen JD; Aguilar-Gaziola S; Bijl R; Borges G; Caraveo-Anduaga JJ; DeWit DJ; Kolody B; Vega WA; Wittchen HU; Kessler RC
    Addict Behav; 1998; 23(6):893-907. PubMed ID: 9801724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
    Fatseas M; Serre F; Swendsen J; Auriacombe M
    Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and substance abuse: prevalence issues.
    el-Guebaly N; Hodgins DC
    Can J Psychiatry; 1992 Dec; 37(10):704-10. PubMed ID: 1473076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychiatric comorbidities in temporal lobe epilepsy in a Southern Brazilian population.
    Bragatti JA; Torres CM; Londero RG; Martin KC; Souza AC; Hidalgo MP; Chaves ML; Bianchin MM
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):159-65. PubMed ID: 21537552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.